Samsara Bio Capital, LLC Rocket Pharmaceuticals, Inc. Transaction History

Samsara Bio Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $322,778 - $674,752	-40,550 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$39.41 - $47.25 $915,100 - $1.1 Million	-23,220 Reduced 36.41%	40,550 $1.8 Million
Q4 2020 Feb 17, 2021	SELL	$23.3 - $59.57 $835,840 - $2.14 Million	-35,873 Reduced 36.0%	63,770 $3.5 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $790,357 - $1.1 Million	-38,554 Reduced 27.9%	99,643 $2.28 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $133,200 - $226,100	10,000 Added 7.8%	138,197 $2.89 Million
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $1.24 Million - $3.22 Million	128,197 New	128,197 $1.79 Million

209

93.2M

319K

70.3K

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $884M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.